Cargando…
A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform
Staphylococcus aureus is a Gram-positive pathogen that is capable of infecting almost every organ in the human body. Alarmingly, the rapid emergence of methicillin-resistant S. aureus strains (MRSA) jeopardizes the available treatment options. Herein, we propose sustainable, low-cost production of r...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175171/ https://www.ncbi.nlm.nih.gov/pubmed/32178236 http://dx.doi.org/10.3390/biom10030435 |
_version_ | 1783524775375667200 |
---|---|
author | Nour El-Din, Hanzada T. Elhosseiny, Noha M. El-Gendy, Mohamed A. Mahmoud, Azza A. Hussein, Manal M. M. Attia, Ahmed S. |
author_facet | Nour El-Din, Hanzada T. Elhosseiny, Noha M. El-Gendy, Mohamed A. Mahmoud, Azza A. Hussein, Manal M. M. Attia, Ahmed S. |
author_sort | Nour El-Din, Hanzada T. |
collection | PubMed |
description | Staphylococcus aureus is a Gram-positive pathogen that is capable of infecting almost every organ in the human body. Alarmingly, the rapid emergence of methicillin-resistant S. aureus strains (MRSA) jeopardizes the available treatment options. Herein, we propose sustainable, low-cost production of recombinant lysostaphin (rLST), which is a native bacteriocin destroying the staphylococcal cell wall through its endopeptidase activity. We combined the use of E. coli BL21(DE3)/pET15b, factorial design, and simple Ni-NTA affinity chromatography to optimize rLST production. The enzyme yield was up to 50 mg/L culture, surpassing reported systems. Our rLST demonstrated superlative biofilm combating ability by inhibiting staphylococcal biofilms formation and detachment of already formed biofilms, compared to vancomycin and linezolid. Furthermore, we aimed at developing a novel rLST topical formula targeting staphylococcal skin infections. The phase inversion composition (PIC) method fulfilled this aim with its simple preparatory steps and affordable components. LST nano-emulgel (LNEG) was able to extend active LST release up to 8 h and cure skin infections in a murine skin model. We are introducing a rapid, convenient rLST production platform with an outcome of pure, active rLST incorporated into an effective LNEG formula with scaling-up potential to satisfy the needs of both research and therapeutic purposes. |
format | Online Article Text |
id | pubmed-7175171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71751712020-04-28 A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform Nour El-Din, Hanzada T. Elhosseiny, Noha M. El-Gendy, Mohamed A. Mahmoud, Azza A. Hussein, Manal M. M. Attia, Ahmed S. Biomolecules Article Staphylococcus aureus is a Gram-positive pathogen that is capable of infecting almost every organ in the human body. Alarmingly, the rapid emergence of methicillin-resistant S. aureus strains (MRSA) jeopardizes the available treatment options. Herein, we propose sustainable, low-cost production of recombinant lysostaphin (rLST), which is a native bacteriocin destroying the staphylococcal cell wall through its endopeptidase activity. We combined the use of E. coli BL21(DE3)/pET15b, factorial design, and simple Ni-NTA affinity chromatography to optimize rLST production. The enzyme yield was up to 50 mg/L culture, surpassing reported systems. Our rLST demonstrated superlative biofilm combating ability by inhibiting staphylococcal biofilms formation and detachment of already formed biofilms, compared to vancomycin and linezolid. Furthermore, we aimed at developing a novel rLST topical formula targeting staphylococcal skin infections. The phase inversion composition (PIC) method fulfilled this aim with its simple preparatory steps and affordable components. LST nano-emulgel (LNEG) was able to extend active LST release up to 8 h and cure skin infections in a murine skin model. We are introducing a rapid, convenient rLST production platform with an outcome of pure, active rLST incorporated into an effective LNEG formula with scaling-up potential to satisfy the needs of both research and therapeutic purposes. MDPI 2020-03-12 /pmc/articles/PMC7175171/ /pubmed/32178236 http://dx.doi.org/10.3390/biom10030435 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nour El-Din, Hanzada T. Elhosseiny, Noha M. El-Gendy, Mohamed A. Mahmoud, Azza A. Hussein, Manal M. M. Attia, Ahmed S. A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform |
title | A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform |
title_full | A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform |
title_fullStr | A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform |
title_full_unstemmed | A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform |
title_short | A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform |
title_sort | rapid lysostaphin production approach and a convenient novel lysostaphin loaded nano-emulgel; as a sustainable low-cost methicillin-resistant staphylococcus aureus combating platform |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175171/ https://www.ncbi.nlm.nih.gov/pubmed/32178236 http://dx.doi.org/10.3390/biom10030435 |
work_keys_str_mv | AT noureldinhanzadat arapidlysostaphinproductionapproachandaconvenientnovellysostaphinloadednanoemulgelasasustainablelowcostmethicillinresistantstaphylococcusaureuscombatingplatform AT elhosseinynoham arapidlysostaphinproductionapproachandaconvenientnovellysostaphinloadednanoemulgelasasustainablelowcostmethicillinresistantstaphylococcusaureuscombatingplatform AT elgendymohameda arapidlysostaphinproductionapproachandaconvenientnovellysostaphinloadednanoemulgelasasustainablelowcostmethicillinresistantstaphylococcusaureuscombatingplatform AT mahmoudazzaa arapidlysostaphinproductionapproachandaconvenientnovellysostaphinloadednanoemulgelasasustainablelowcostmethicillinresistantstaphylococcusaureuscombatingplatform AT husseinmanalmm arapidlysostaphinproductionapproachandaconvenientnovellysostaphinloadednanoemulgelasasustainablelowcostmethicillinresistantstaphylococcusaureuscombatingplatform AT attiaahmeds arapidlysostaphinproductionapproachandaconvenientnovellysostaphinloadednanoemulgelasasustainablelowcostmethicillinresistantstaphylococcusaureuscombatingplatform AT noureldinhanzadat rapidlysostaphinproductionapproachandaconvenientnovellysostaphinloadednanoemulgelasasustainablelowcostmethicillinresistantstaphylococcusaureuscombatingplatform AT elhosseinynoham rapidlysostaphinproductionapproachandaconvenientnovellysostaphinloadednanoemulgelasasustainablelowcostmethicillinresistantstaphylococcusaureuscombatingplatform AT elgendymohameda rapidlysostaphinproductionapproachandaconvenientnovellysostaphinloadednanoemulgelasasustainablelowcostmethicillinresistantstaphylococcusaureuscombatingplatform AT mahmoudazzaa rapidlysostaphinproductionapproachandaconvenientnovellysostaphinloadednanoemulgelasasustainablelowcostmethicillinresistantstaphylococcusaureuscombatingplatform AT husseinmanalmm rapidlysostaphinproductionapproachandaconvenientnovellysostaphinloadednanoemulgelasasustainablelowcostmethicillinresistantstaphylococcusaureuscombatingplatform AT attiaahmeds rapidlysostaphinproductionapproachandaconvenientnovellysostaphinloadednanoemulgelasasustainablelowcostmethicillinresistantstaphylococcusaureuscombatingplatform |